Trifluridine/Tipiracil and Oxaliplatin as Induction Chemotherapy in Resectable Esophageal and Gastroesophageal Junction Adenocarcinoma: A Phase II Study
Authors
Anthony George (ORCID: https://orcid.org/0000-0002-2709-126X)
Trifluridine/Tipiracil and Oxaliplatin as Induction Chemotherapy in Resectable Esophageal and Gastroesophageal Junction Adenocarcinoma: A Phase II Study
Anthony George, Kristopher Attwood, Sarah Chatley, Han Yu et al.
Journal
Cancer Medicine
Topics
Esophageal Cancer Research and Treatment
article
Trifluridine/Tipiracil and Oxaliplatin as Induction Chemotherapy in Resectable Esophageal and Gastroesophageal Junction Adenocarcinoma: A Phase II Study
Anthony George, Kristopher Attwood, Sarah Chatley, Han Yu, Christos Fountzilas, Kayla Catalfamo, Deepak Vadehra, Sagila George, Harsha Pattnaik, Renuka Iyer, Hassan Hatoum, Moshim Kukar, Erik Spickard, Yu Fujiwara, Chih‐Yi Liao, Alyson N. Brown, Shailesh Advani, Sarbajit Mukherjee, Arkarachai Fungtammasan
article en
Abstract
No abstract available for this paper.
Publication Tag
Cancer MedicineVol. 14(7)
Institutions
Baptist Hospital of Miami (US), Roswell Park Comprehensive Cancer Center (US), University of Chicago Medical Center (US), Baptist Health South Florida (US), Natera (United States) (US), University of Oklahoma Health Sciences Center (US)
Funders
Roswell Park Cancer Institute, National Comprehensive Cancer Network, National Cancer Institute
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Trifluridine/Tipiracil and Oxaliplatin as Induction Chemotherapy in Resectable Esophageal and Gastroesophageal Junction Adenocarcinoma: A Phase II Study — Anthony George, Kristopher Attwood, et al. · Cancer Medicine (2025) | TGRS Research Map | TGRS